Feds publish long-COVID disability coverage guidelines … Genesis’ targeted COVID-19 vaccine efforts increased uptake among Black, Hispanic employees … Israel may recommend Pfizer’s COVID-19 booster...
CMS to weigh national Medicare coverage for Aduhelm, other Alzheimer’s drugs
By
Alicia Lasek
Jul 14, 2021
The agency is considering whether to establish a national coverage policy for monoclonal antibody drugs that treat Alzheimer’s disease, including the newly approved drug aducanumab (Aduhelm).
Panel on non-invasive ventilation seeks to simplify ‘maze’ of regulation for device coverage
By
Alicia Lasek
Aug 20, 2021
Recommendations aimed at expediting CMS coverage determinations for non-invasive ventilation devices could help ensure that LTCF residents and others get quick access to lifesaving treatments.
Brooks-LaSure: Medicare poised to re-evaluate coverage of new Alzheimer’s drugs
By
Alicia Lasek
Dec 12, 2022
In a Milken Institute summit session, the CMS administrator said that Medicare’s door is open to evaluating new data on emerging Alzheimer’s drug candidates.